Free Trial
CVE:HEM

Hemostemix (HEM) Stock Price, News & Analysis

Hemostemix logo
C$0.14 +0.01 (+3.70%)
As of 07/11/2025 03:56 PM Eastern

About Hemostemix Stock (CVE:HEM)

Key Stats

Today's Range
C$0.14
C$0.15
50-Day Range
C$0.08
C$0.15
52-Week Range
C$0.04
C$0.43
Volume
80,050 shs
Average Volume
403,727 shs
Market Capitalization
C$20.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HEM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter.

HEM Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Hemostemix Closes $469,366 Private Placement
See More Headlines

HEM Stock Analysis - Frequently Asked Questions

Hemostemix's stock was trading at C$0.12 at the beginning of 2025. Since then, HEM stock has increased by 16.7% and is now trading at C$0.14.

Shares of HEM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hemostemix investors own include Iplayco (IPC), Capricor Therapeutics (CAPR), Golden Share Resources (GSH), Nuvilex (PMCB), Algernon Pharmaceuticals (AGNPF), Defense Metals (DFMTF) and NIO (NIO).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:HEM
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$5.00 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
37.07%
Return on Assets
-349.24%

Debt

Debt-to-Equity Ratio
-55.07
Current Ratio
0.04
Quick Ratio
0.48

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.01 per share
Price / Cash Flow
10.77
Book Value
C($0.10) per share
Price / Book
-1.41

Miscellaneous

Outstanding Shares
145,727,000
Free Float
N/A
Market Cap
C$20.40 million
Optionable
Not Optionable
Beta
0.20
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (CVE:HEM) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners